Possibilities and limits of the medical treatment for primary hyperparathyroidism.
Clinically obvious primary hyperparathyroidism is only curable by surgery. Medical treatment is debatable under other circumstances: mild chronic hypercalcemia, patients who refuse surgery, serious coexisting medical problems and recurrence or persistence of PHPT after surgical treatment. Prior to medical treatment, the usual common management of any mild hypercalcemia must be taken. The potential medical treatments are: (1) the inhibition of parathyroid hormone (PTH) secretion, and (2) the inhibition of the effects of PTH. The substances of these two main types are successively described. Nevertheless, no ideal medical treatment of PHPT is actually available.
Lefebvre
J
J
Service d'Endocrinologie et Métabolismes, CHU de Lille, France.
D004999:Amifostine / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D006961:Hyperparathyroidism / Q000150:complications / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000378:metabolism
D010281:Parathyroid Hormone; D004999:Amifostine